Showing 17,021 - 17,040 results of 18,626 for search '"Therapy"', query time: 0.11s Refine Results
  1. 17021

    Trastuzumab Resistance: Role for Notch Signaling by Kinnari Mehta, Clodia Osipo

    Published 2009-01-01
    “…Here we review the many possible mechanisms of action that could contribute to resistance, and novel therapies to prevent or reverse the resistant phenotype. …”
    Get full text
    Article
  2. 17022

    Innovative nanoparticle-based approaches for modulating neutrophil extracellular traps in diseases: from mechanisms to therapeutics by Haisong Li, Can Li, Cong Fu, Yizhuo Wang, Tingting Liang, Haitao Wu, Chenxi Wu, Chang Wang, Tianmeng Sun, Shuhan Liu

    Published 2025-02-01
    “…Additionally, we address the current challenges and future prospects for NP-based therapies in NET research, aiming to bridge the gap between nanotechnology and NET modulation for the development of novel therapeutic approaches. …”
    Get full text
    Article
  3. 17023

    DKK1 and Its Receptors in Esophageal Adenocarcinoma: A Promising Molecular Target by Markos Despotidis, Orestis Lyros, Tatiana S. Driva, Panagiotis Sarantis, Emmanouil I. Kapetanakis, Adam Mylonakis, Andreas Mamilos, Stratigoula Sakellariou, Dimitrios Schizas

    Published 2025-01-01
    “…Despite the recent progress in targeted therapies and surgical approaches, the survival rates of esophageal adenocarcinoma patients remain poor. …”
    Get full text
    Article
  4. 17024

    Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing by Margeaux Hodgson-Garms, Matthew J. Moore, Mikaël M. Martino, Kilian Kelly, Jessica E. Frith

    Published 2025-02-01
    “…The data and findings from this study will inform the optimum MSC source for particular applications and underpin further development of MSC therapies.…”
    Get full text
    Article
  5. 17025

    Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells by Huangde Fu, Shengtian Wu, Hechun Shen, Kai Luo, Zhongxiang Huang, Nankun Lu, Yaolin Li, Qian Lan, Yishun Xian

    Published 2025-02-01
    “…Conclusively, the current report provides evidence that DHA, PI3K/Akt/EphA2 blockage, and VM inhibition are promising therapies for glioma.…”
    Get full text
    Article
  6. 17026

    Understanding Obesity and the Role of Pharmacological Treatments: Insights for Health and Fitness Enthusiasts by Agnieszka Starzyk, Piotr Charzewski

    Published 2025-02-01
    “…The integration of genetic diagnostics into clinical practice is critical to identifying appropriate candidates for these therapies and personalizing treatment plans to address the heterogeneous nature of obesity. …”
    Get full text
    Article
  7. 17027

    The impact of climate change on the epidemiology of fungal infections: implications for diagnosis, treatment, and public health strategies by Mary E. George, Tonisha T. Gaitor, David B. Cluck, Andrés F. Henao-Martínez, Nicholas R. Sells, Daniel B. Chastain

    Published 2025-02-01
    “…Immediate action is required to develop policies, educational initiatives, and novel antifungal therapies, enhance early diagnostic capabilities, and address healthcare disparities to mitigate the growing burden of fungal infections.…”
    Get full text
    Article
  8. 17028

    Update on Clinical Inflammometry for the Management of Airway Diseases by Parameswaran Nair

    Published 2013-01-01
    “…However, most treatment recommendations, including the use of anti-inflammatory therapies such as corticosteroids, are based on assessments of only airflow and symptoms. …”
    Get full text
    Article
  9. 17029

    Novel Strategies for the Improvement of Stem Cells’ Transplantation in Degenerative Retinal Diseases by Simona Delia Nicoară, Sergiu Șușman, Oana Tudoran, Otilia Bărbos, Gabriela Cherecheș, Simion Aștilean, Monica Potara, Olga Sorițău

    Published 2016-01-01
    “…The feasibility of SCs based therapies for degenerative retinal diseases was proved in the preclinical setting. …”
    Get full text
    Article
  10. 17030
  11. 17031

    The Convergence of Nanotechnology, Biotechnology and Cancer Medicine in the Fourth Industrial Revolution by Steven Mufamadi, Zamanzima Mazibuko

    Published 2019-10-01
    “… Medical technologies of the fourth industrial revolution (Industry 4.0), such as nanotechnology, biotechnology, artificial  intelligence (AI), 3D printing and advanced materials are already transforming medical technology and the pharmaceutical industry by offering accurate diagnoses, targeting therapies with fewer side effects, and providing better medical imaging and personalised medicine. …”
    Get full text
    Article
  12. 17032

    Underlying Anticancer Mechanisms and Synergistic Combinations of Phytochemicals with Cancer Chemotherapeutics: Potential Benefits and Risks by Muhammad Ayaz, Asif Nawaz, Sajjad Ahmad, Osama F. Mosa, Alashary Adam Eisa Hamdoon, Modawy Alnour Khalifa, Abdul Sadiq, Farhat Ullah, Abdul Wadood, Atul Kabra, H. C. Ananda Murthy

    Published 2022-01-01
    “…Cancer therapies are associated with various challenges including the emergence of multidrug resistant tumors, toxicological issues, severe side effects, and economic burden. …”
    Get full text
    Article
  13. 17033

    Unmasking Multiple Myeloma: The Importance of Suspecting Malignancy in Atypical Chronic Pain Mimicking Degenerative Conditions—A Case Report by Bi Mo, Sandra Sacks, Jerry Markar

    Published 2025-01-01
    “…This underscores the necessity of a thorough evaluation when symptoms are refractory to conventional therapies, in order to facilitate timely diagnosis and effective management of malignancy.…”
    Get full text
    Article
  14. 17034

    Genetic and Biochemical Alterations in Non-Small Cell Lung Cancer by Jackie L. Johnson, Smitha Pillai, Srikumar P. Chellappan

    Published 2012-01-01
    “…This has facilitated the development of potent and specific targeted therapies, based on the genetic and biochemical alterations present in the tumor, especially non-small-cell lung cancer (NSCLC). …”
    Get full text
    Article
  15. 17035

    Reconstructing the Stem Leydig Cell Niche via the Testicular Extracellular Matrix for the Treatment of Testicular Leydig Cell Dysfunction by Ani Chi, Chao Yang, Jie Liu, Zhichen Zhai, Xuetao Shi

    Published 2025-01-01
    “…Abstract Therapies involving the use of stem Leydig cells (SLCs), as testicular mesenchymal stromal cells, have shown great promise in the treatment of Leydig cell (LC) dysfunction in aging males. …”
    Get full text
    Article
  16. 17036

    RNA modifications in cancer by Han Wu, Shi Chen, Xiang Li, Yuyang Li, He Shi, Yiwen Qing, Bohe Shi, Yifei Tang, Zhuoyi Yan, Yang Hao, Dongxu Wang, Weiwei Liu

    Published 2025-01-01
    “…Furthermore, RNA modifications’ potential in cancer therapies, including conventional treatments, immunotherapy, and targeted therapies, is discussed. …”
    Get full text
    Article
  17. 17037

    Promising New Treatments for Psoriasis by Sarah Dubois Declercq, Roxane Pouliot

    Published 2013-01-01
    “…Biological drugs are less toxic to the body and more effective than traditional therapies. Thus, they should improve the quality of life of patients with psoriasis. …”
    Get full text
    Article
  18. 17038

    Cytosolic DNA composition is determined by genomic instability mechanism and regulates dendritic cell-mediated anti-tumor immunity by Shayla R. Mosley, Angie Chen, David N.W. Doell, Siwon Choi, Courtney Mowat, Felix Meier-Stephenson, Vanessa Meier-Stephenson, Kristi Baker

    Published 2025-02-01
    “…Identifying highly stimulatory endogenous cyDNAs such as those in MSI CRCs will allow for optimized development of DNA-based STING agonist therapies to improve the responses of CIN CRCs with CIN to immunotherapies.…”
    Get full text
    Article
  19. 17039

    Brain-Derived Neurotrophic Factor and Nerve Growth Factor Therapeutics for Brain Injury: The Current Translational Challenges in Preclinical and Clinical Research by Serena-Kaye Sims, Brynna Wilken-Resman, Crystal J. Smith, Ashley Mitchell, Lilly McGonegal, Catrina Sims-Robinson

    Published 2022-01-01
    “…This review will focus on the administration of these neurotrophic factors in preclinical and clinical stroke and TBI and the challenges in translating these therapies from the bench to the clinic.…”
    Get full text
    Article
  20. 17040

    Neural Compensations After Lesion of the Cerebral Cortex by Bryan Kolb, Russell Brown, Alane Witt-Lajeunesse, Robbin Gibb

    Published 2001-01-01
    “…For example, behavioral therapies may act, in part, via their action in stimulating the endogenous production of trophic factors. …”
    Get full text
    Article